PRISONERS
PRISONERS OUT EARLY IF THEY GET AN EDUCATION AND JOB TRAINING.
>> +@
>> +@
>> +@ >>>
>> +@ >>> DRUGGED AND DYING, TONIGHT
A SPOTLIGHT ON THE +@
PHARMACEUTICAL SCENE IS PUTTING
LIVES AT RISK.
THEY ARE -- ONE FAMILY IS
SAYING THEIR FAMILY PAID FOR IT
WITH A LIFE.>> JESSE STAGNER'S
DOWNWARD SPIRAL BEGAN LIKE SO
MANY OTHERS HER AGE.>> SHE FELL
AND BROKE HER HIP AND THAT WAS
THE BEGINNING OF THE END.
>> JERRY DOESN'T BLAME HIS
MOTHER-IN-LAW'S DEATH ON THE
FALL, INSTEAD, HE BLAMES THE
DRUG HE SAID SHE WAS ON WHEN
SHE FELL.
SHE FELL.
SHE FELL. >> I'M VERY UPSET.>> THEY SAID
SHE WAS IN VERY GOOD HEALTH,
BUT SHE WAS SHOWING SIGNS OF
DEMENTIA. +@
DEMENTIA. +@ THAT'S WHEN HE SAYS THE DOCTOR
STARTED PRESCRIBING HER RIFF
SPREAD ALL.>> IT REALLY
IMMOBILIZED HER, SHE COULDN'T
WALK WITHOUT SOMEONE HOLDING
HER OR IN A WHEELCHAIR.
>> IT WAS REALLY SAD.
SHE WAS A SPECIAL, SPECIAL
LADY.
LADY.
LADY. >>
LADY. >> WHAT THEY DIDN'T KNOW WAS
THAT THE FDA NEVER APPROVED
RISPERDAL TO TREAT SYMPTOMS OF
DEMENTIA.
DEMENTIA.
DEMENTIA. IN FACT, THE FDA HAD ISSUED A
BLACKBOX WARNING, LINKING THE
DR+@UG TO AN INCREASED RISK OF
DEATH AMONG ELDERLY DEMENTIA
PATIENTS.
PATIENTS.
PATIENTS. BUT STILL, DOCTORS IN NURSING
HOMES ACROSS TEXAS COMMONLY
PRESCRIBED THE DRUG TO DEMENTIA
PATIENTS LIKE JESSE WHO CALMED
THEM DOWN.
THEM DOWN. >> THERE ARE SIGNIFICANT RISKS
THAT ARE ASSOCIATED WITH THAT.
>> DOCTOR DANIEL PEARSON>>
INCREASED RISK OF CARDIAC
DEATH, FALLING, BREAKING A HIP.
>> THAT IS EXACTLY WHAT THEY
SAY HAPPENED TO JESSE.
>> I DON'T THINK SHE+@ WOULD HA
FALLEN IF SHE HADN'T BEEN ON
RISPERDAL.
RISPERDAL. SHE WAS STILL HEALTHY AND
STRONG, I THINK SHE WOULD HAVE
LIVED TELL 100, EASY.
>> JESSE'S NURSING HOME I
STILL USING THEM.
ACCORDING THE ALIYSOWN
RECORDS, MORE THAN 25%O H
RESIDECONT AE
RESIDECONT AE ANTIPSYOSRUE O
ANTIPSYOSRUE O APPROVD THE FDA.
THAT IS COMMON IN TEXAS.
OUR ANALYSIS OF FEDERAL NURSING
HOME DATA FOUND NINE OUT OF 10
T+@EXAS N+@URSING HOMES ADI DOI
THE SAME THING WITH SIMILAR
DRUGS.
DRUGS.
DRUGS. USING POWERFUL ANTIPSYCHOTICS
FOR REASO O APPOE BY THE
FDA.
FDA.
FDA. SO,
FDA. SO, IF THE FDA SAYS RESPITE ALL
-- SAYS RISPERDAL IS NOT SAFE ,
THEN WHY ARE SO MANY DARK
ERRORS USING IT -- SO MANY
DOCTORS USI+@NG+@ IT FOR +@HT
PURPOSE?
PURPOSE?
PURPOSE? THE ANSWERS MIGHT LIE WITHIN
JANSSEN PHARMACEUTI+@CL.
JANSSEN PHARMACEUTI+@CL. LET'S GO BA TO 1993.
RISPERDAL WAS A NEW DRUG, THE
FDA APPROVED IT TO TREAT
SCHIZOPHRENIA AND BIPOLAR
DISORDER. +@
DISORDER. +@ BUT THAT +@IS A PRETTY SMALL
MARKET.
MARKET.
MARKET. DEMENTIA PATIE+@NTS HOWEVER, MA
MARKET. DEMENTIA PATIE+@NTS HOWEVER, MA@
UP A MARCH -- A MUCH L+@ARGER
POPULATION.
POPULATION. IN ORDER TO EXPAND THE MARKET,
FEDERAL AND STATE ATTORNEYS
ARGUED THAT JOHNSON AND JOHNSON
DEVELOPED THE SCHEME TO TURN
THE DRUG INTO A BLOCKBUSTER.
THEY USED TEXAS AS THE MODEL
STATE TO DO I+@T.
THE GOAL, GET DOCTORS TO
PRESCRIBE RISPERDAL OVER OTHER
DRUGS AND FOR CONDITIONS LIKE
DEMENTIA THAT THE FDA HAD NOT
APPROVED IT FOR, THAT IS KNOWN
AS OFF LABEL USE.>> AND OFF
LABEL USE OF THE +@DRUG IS NOT
ILLEGAL.
ILLEGAL.
ILLEGAL. >> MICHAEL ELLIOTT SPECIALIZED
IN HEALTHCARE FRAUD, HE SAYS
DOCTORS COMMONLY USED DRUGS OFF
LABEL, THAT IS NOT THE PROBLEM.
>> WHAT IS INAPPROPRIATE IS FOR
A DRUG COMPANY TO MARKET THAT
DRUG FOR OFF LABEL USES.
>> JOHNSON & JOHNSON DID IT
ANYWAY, FIRST THEY RECRUITED
INFLUENTIAL DOCTORS LIKE
STEPHEN SHAWN, HE WAS THE
MEDICAL DIRECTOR FOR THE TEXAS
DEPARTMENT OF MENTAL HEALTH,
STATE ATTORNEYS ALLEGED THAT
JOHNSON & JOHNSON MADE A SERIES
OF ILLEGAL PAYMENTS TO DOCTOR
SEAN THAT EFFECTIVELY TURNED
HIM INTO A SALESMAN FOR
RISPERDAL.
RISPERDAL. RECORDS OBTAINED SHOW THE
COMPANY PAID HIM THOUSANDS.
BUT IN TESTIMONY, DOCTOR SEAN
SAID THE MONEY DIDN'T INFLUENCE
HIM.
HIM.
HIM. THE
HIM. THE COMPANY ALSO PAID LUCRATIVE
FEES TO A MAJOR PHARMACY
PROVIDER TO PROMOTE THE DRUG IN
NURSING HOMES.
NURSING HOMES. AND DESPITE THE FDA'S WARNING
THAT USING RISPERDAL TO TREAT
ELDERLY DIMENSIONAL --
DEMENTIA PATIENTS WAS
DANGEROUS, THEY SHOW JOHNSON &
JOHNSON CREATED A SALESFORCE
THEY CALLED ELDERCARE, THE
+@
THEY CALLED ELDERCARE, THE OBJECTIVE?
OBJECTIVE? TARGET DEMENTIA PATIENTS.
FROM THE LATE 90s TO 2004,
SALES REPS MADE THOUSANDS OF
CALLS PROMOTING THE DRUG AS
SAFE AND EFFECTIVE FOR TREATING
BEHAVIOR PROBLEMS IN ELDERLY
DEMENTIA PATIENTS.
DEMENTIA PATIENTS. AND IT WORKED.
PROFITS ROLLED IN.
DOMESTIC SALES OF RISPERDAL
INCREASED FROM 892 MILLION TO
2 BILLION PER YEAR.
ACCORDING TO JOHNSON &
JOHNSON'S OWN MARKET RESEARCH,
AS MUCH AS 75% OF THE
PRESCRIPTION FOR RISPERDAL WERE
FOR OUR -- WERE FOR OFF LABEL
USES.
USES.
USES. EVENTUALLY, THE COMPANY GOT
FOUGHT -- GOT CAUGHT AND IN
2013, JOHNSON & JOHNSON DECIDED
TO SETTLE.
TO SETTLE. NO EMPLOYEE WAS EVER CRIMINALLY
CHARGED.
CHARGED.
CHARGED. AS PART OF A SETTLEMENT IN A
STATEMENT THE COMPANY TELLS
NEWS EIGHT, IT HAS ROBUST
COMPLIANCE PROGRAMS THAT HAVE
BEEN CONTINUALLY STRENGTHENED
THE PROGRAMS REFLECT THE
COMPANY'S COMMITMENT TO
ENSURING INTEGRITY IN THE
+@
+@ DELIVERY OF ESSENTIAL MEDICINE
TO THE PATIENT'S.
THE COMPANY PAID A TOTAL OF
$2.2 BILLION, IT WAS THE
LARGEST HEALTHCARE FRAUD PHILIP
-- FRAUD SETTLEMENT OF ITS KIND
IN HISTORY.
IN HISTORY. >> WHEN WE ARE TALKING ABOUT
THE PROFIT MARGINS, FOR JOHNSON
& JOHNSON ON+@ THAT SPECIFIC
DRUG, YOU CAN REALLY SEE IT AS
JUST THE COST OF DOING
BUSINESS.
BUSINESS.
BUSINESS. >> BUT THE COST IS MUCH HIGHER
FOR FAMILIES LIKE THEM, THE
MASSIVE SETTLEMENT HAS NOT
CHANGE+@D THE WAY MANY DOCTORS @
ARE ST+@ILL PRESCRIBING THE DRU
AND FOR THAT, THEY SAY HIS
FAMILY PAID THE ULTIMATE
PRICE.>> WE NEED TO FIGURE OUT
A WAY TO STOP IT, BECAUSE THE
KEY TO HEALING, TO A GOOD LIFE,
IS KNOWLEDGE.>> IF YOU HAVE A
LOVED ONE IN A NU+@RSING HOM+@E
DOCTORS SAY DO YOUR HOMEWORK,
FIND OUT WHAT PRE+@SCRIPTION
THEY AEON AN WHY.
IF THE NUR+@SING HOME WON'T GIV
YOU ACCESS